Login
Toggle sidebar

Lint: mass-forming-intrahepatic-cholangiocarcinoma

Headings Spacing
error

"Macroscopic appearance "

Line 11:1 · Never put spaces at either end of headings.
Strong List Colon Position
error

"T1: hypointense 7"

Line 41:1 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> hypointense'

"T2: hyperintense 7"

Line 44:1 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> hyperintense'

"DWI: target sign of diffusion restriction at high b values"

Line 47:1 · When enboldening an intro, the colon should not be bold. '<strong>DWI:</strong> '
Acronyms
warning

"Reported mutations associated with mass-forming cholangiocarcinoma include KRAS, TP53, DH1/2, FGFR2 fusions, BAP1, BRAF, ARID1A, SMAD4, and IDH1 8."

Line 14:79 · 'KRAS' has no definition. Spell it out if it's unfamiliar to the audience.

"Reported mutations associated with mass-forming cholangiocarcinoma include KRAS, TP53, DH1/2, FGFR2 fusions, BAP1, BRAF, ARID1A, SMAD4, and IDH1 8."

Line 14:119 · 'BRAF' has no definition. Spell it out if it's unfamiliar to the audience.
Strong
warning

"T1: hypointense 7"

Line 41:1 · Generally, don't use bold in text: '<strong>T1:</strong>'

"T2: hyperintense 7"

Line 44:1 · Generally, don't use bold in text: '<strong>T2:</strong>'

"DWI: target sign of diffusion restriction at high b values"

Line 47:1 · Generally, don't use bold in text: '<strong>DWI:</strong>'

"T1 C+ (Primovist)pattern and intensity of enhancement has been associated with tumour differentiation and, therefore, prognosis 6"

Line 53:1 · Generally, don't use bold in text: '<strong>T1 C+ (Primovist)</strong>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Macroscopic appearance "

Line 11:1 · "Macroscopic appearance " is not a recognised heading for this article type.

"MRI​"

Line 38:1 · "MRI​" is not a recognised heading for this article type.
Commas
suggestion

"Reported mutations associated with mass-forming cholangiocarcinoma include KRAS, TP53, DH1/2, FGFR2 fusions, BAP1, BRAF, ARID1A, SMAD4, and IDH1 8."

Line 14:83 · More than 5 commas in a single sentence might make it more difficult to read.